Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 20156956)

1.

Comparative study of outcome measures and analysis methods for traumatic brain injury trials.

Alali AS, Vavrek D, Barber J, Dikmen S, Nathens AB, Temkin NR.

J Neurotrauma. 2015 Apr 15;32(8):581-9. doi: 10.1089/neu.2014.3495. Epub 2015 Feb 9.

PMID:
25317951
2.

Update of the Preventive Antibiotics in Stroke Study (PASS): statistical analysis plan.

Westendorp WF, Vermeij JD, Dippel DW, Dijkgraaf MG, van der Poll T, Prins JM, Vermeij FH, Roos YB, Brouwer MC, Zwinderman AH, van de Beek D, Nederkoorn PJ.

Trials. 2014 Oct 1;15:382. doi: 10.1186/1745-6215-15-382.

3.

MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.

Fransen PS, Beumer D, Berkhemer OA, van den Berg LA, Lingsma H, van der Lugt A, van Zwam WH, van Oostenbrugge RJ, Roos YB, Majoie CB, Dippel DW; MR CLEAN Investigators.

Trials. 2014 Sep 1;15:343. doi: 10.1186/1745-6215-15-343.

4.

Outcomes and statistical power in adult critical care randomized trials.

Harhay MO, Wagner J, Ratcliffe SJ, Bronheim RS, Gopal A, Green S, Cooney E, Mikkelsen ME, Kerlin MP, Small DS, Halpern SD.

Am J Respir Crit Care Med. 2014 Jun 15;189(12):1469-78. doi: 10.1164/rccm.201401-0056CP.

PMID:
24786714
5.

The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies.

Kahan BC, Jairath V, Doré CJ, Morris TP.

Trials. 2014 Apr 23;15:139. doi: 10.1186/1745-6215-15-139.

6.

Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial.

Westendorp WF, Vermeij JD, van Geloven N, Dippel DW, Dijkgraaf MG, van der Poll T, Prins JM, Spanjaard L, Vermeij FH, Nederkoorn PJ, van de Beek D.

Trials. 2014 Apr 21;15:133. doi: 10.1186/1745-6215-15-133.

7.

Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.

Bath PM, Houlton A, Woodhouse L, Sprigg N, Wardlaw J, Pocock S; ENOS Trialists.

Int J Stroke. 2014 Apr;9(3):372-4. doi: 10.1111/ijs.12235. Epub 2014 Mar 3.

8.

The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes.

Garofolo KM, Yeatts SD, Ramakrishnan V, Jauch EC, Johnston KC, Durkalski VL.

Trials. 2013 Apr 11;14:98. doi: 10.1186/1745-6215-14-98.

9.

Advancing care for traumatic brain injury: findings from the IMPACT studies and perspectives on future research.

Maas AI, Murray GD, Roozenbeek B, Lingsma HF, Butcher I, McHugh GS, Weir J, Lu J, Steyerberg EW; International Mission on Prognosis Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Study Group.

Lancet Neurol. 2013 Dec;12(12):1200-10. doi: 10.1016/S1474-4422(13)70234-5. Epub 2013 Oct 17.

10.

Study of therapeutic hypothermia (32 to 35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial): outcome of the pilot phase of the trial.

Andrews PJ, Sinclair LH, Harris B, Baldwin MJ, Battison CG, Rhodes JK, Murray G, De Backer D; Eurotherm3235Trial collaborators.

Trials. 2013 Sep 3;14:277. doi: 10.1186/1745-6215-14-277.

11.

Adjusting for multiple prognostic factors in the analysis of randomised trials.

Kahan BC, Morris TP.

BMC Med Res Methodol. 2013 Jul 31;13:99. doi: 10.1186/1471-2288-13-99.

12.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

13.

New considerations in the design of clinical trials for traumatic brain injury.

Roozenbeek B, Lingsma HF, Maas AI.

Clin Investig (Lond). 2012 Feb;2(2):153-162.

14.

Citalopram for agitation in Alzheimer's disease: design and methods.

Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG; CitAD Research Group.

Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.

15.

Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the brain trauma foundation TBI-trac® New York State database.

Roozenbeek B, Chiu YL, Lingsma HF, Gerber LM, Steyerberg EW, Ghajar J, Maas AI.

J Neurotrauma. 2012 May 1;29(7):1306-12. doi: 10.1089/neu.2011.1988. Epub 2012 Jan 26.

16.

Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?

Weir J, Steyerberg EW, Butcher I, Lu J, Lingsma HF, McHugh GS, Roozenbeek B, Maas AI, Murray GD.

J Neurotrauma. 2012 Jan 1;29(1):53-8. doi: 10.1089/neu.2011.2137.

17.

Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials.

Lu J, Marmarou A, Lapane KL; IMPACT Investigators.

J Neurotrauma. 2012 Mar 20;29(5):719-26. doi: 10.1089/neu.2010.1746. Epub 2011 Sep 21.

18.

Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.

Saver JL.

Stroke. 2011 Aug;42(8):2356-62. doi: 10.1161/STROKEAHA.111.619122. Epub 2011 Jun 30. Review. Erratum in: Stroke. 2011 Nov;42(11):e634.

19.

The added value of ordinal analysis in clinical trials: an example in traumatic brain injury.

Roozenbeek B, Lingsma HF, Perel P, Edwards P, Roberts I, Murray GD, Maas AI, Steyerberg EW; IMPACT (International Mission on Prognosis and Clinical Trial Design in Traumatic Brain Injury) Study Group; CRASH (Corticosteroid Randomisation After Significant Head Injury) Trial Collaborators.

Crit Care. 2011;15(3):R127. doi: 10.1186/cc10240. Epub 2011 May 17.

20.

Underpowered trials in critical care medicine: how to deal with them?

Roozenbeek B, Lingsma HF, Steyerberg EW, Maas AI; IMPACT Study Group.

Crit Care. 2010;14(3):423. doi: 10.1186/cc9021. Epub 2010 Jun 8. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk